These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Disposition of foscarnet during peritoneal dialysis. Alexander AC; Akers A; Matzke GR; Aweeka FT; Fraley DS Ann Pharmacother; 1996 Oct; 30(10):1106-9. PubMed ID: 8893116 [TBL] [Abstract][Full Text] [Related]
12. Changing acute renal failure treatment from intermittent hemodialysis to continuous hemofiltration: impact on azotemic control. Bellomo R; Farmer M; Bhonagiri S; Porceddu S; Ariens M; M'Pisi D; Ronco C Int J Artif Organs; 1999 Mar; 22(3):145-50. PubMed ID: 10357242 [TBL] [Abstract][Full Text] [Related]
13. The impact of residual renal function on the adequacy of peritoneal dialysis. Lameire NH Nephron; 1997; 77(1):13-28. PubMed ID: 9380234 [No Abstract] [Full Text] [Related]
14. Peritoneal Dialysis for Acute Kidney Injury Treatment in the United States: Brought to You by the COVID-19 Pandemic. Srivatana V; Aggarwal V; Finkelstein FO; Naljayan M; Crabtree JH; Perl J Kidney360; 2020 May; 1(5):410-415. PubMed ID: 35369379 [No Abstract] [Full Text] [Related]
15. Continuous flow peritoneal dialysis (CFPD) improves ultrafiltration in children with acute kidney injury on conventional PD using a 4.25 % dextrose solution. Nourse P; Sinclair G; Gajjar P; du Plessis M; Argent AC Pediatr Nephrol; 2016 Jul; 31(7):1137-43. PubMed ID: 26879802 [TBL] [Abstract][Full Text] [Related]
16. Peritoneal dialysis in renal failure. A case report. PRINS LR; MENEFEE EC Minn Med; 1962 Aug; 45():805-7. PubMed ID: 14488811 [No Abstract] [Full Text] [Related]